BSI Team Joins Forces With Oragenics in Search for New Antibiotics
A biophysics team led by Florida International University researchers Prem Chapagain and Bernard Gerstman has joined forces with UF Innovate | Sid Martin Biotech resident client Oragenics Inc. in an effort that could lead to the development of new compounds to treat life-threatening infections.
Oragenics develops antibiotics that can be used against infectious diseases and treatments for oral mucositis, a condition caused by cancer treatments in which painful sores develop in the patient’s mouth. As part of this new collaboration, FIU will create computational models to study the company’s